Current Report Filing (8-k)
August 03 2017 - 06:46AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of
earliest event reported): August 3, 2017
THE
CLOROX COMPANY
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
|
1-07151
(Commission File Number)
|
31-0595760
(I.R.S. Employer
Identification No.)
|
1221
Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)
(510) 271-7000
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 Under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR 240.12b-2).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
¨
Item 2.02 Results of Operations and Financial Condition
On August 3, 2017, The Clorox Company issued
a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2017. The full text of the
press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure
Attached hereto as Exhibit 99.2 and incorporated
herein by reference is supplemental financial information.
Item 9.01 Financial Statements and Exhibits
(d)
|
Exhibits
|
|
|
|
|
|
Exhibit
|
Description
|
|
99.1
|
Press Release dated August 3, 2017 of The Clorox Company
|
|
99.2
|
Supplemental information regarding financial results
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
THE CLOROX COMPANY
|
|
|
|
Date:
August 3, 2017
|
By:
|
/s/
Laura Stein
|
|
|
Executive
Vice President
General Counsel and
Corporate Affairs
|
THE CLOROX COMPANY
FORM 8-K
INDEX TO EXHIBITS
Clorox (NYSE:CLX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Clorox (NYSE:CLX)
Historical Stock Chart
From Mar 2023 to Mar 2024